Resources Contact Us Home
Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis

Image Number 15 for United States Patent #7285268.

The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same.

  Recently Added Patents
Nuclear fission reactor, a vented nuclear fission fuel module, methods therefor and a vented nuclear fission fuel module system
Targeted gene deletions for polysaccharide slime formers
Magnetoresistive shield with coupled lateral magnet bias
Universal data-driven computer proxy
Video processing system and device with encoding and decoding modes and method for use therewith
Low cost mesh network capability
Subpixel-based image down-sampling
  Randomly Featured Patents
Golf club head
Low-voltage differential amplifier
Soft value calculation for multilevel signals
Interconnection system for transmitting power between electrical systems
Composition for laser marking
Mechanical and digital reading pen
Vehicle vision system
Wheelchair loading apparatus
Airship retrieval system
Housing for electrical measuring, monitoring, regulating and controlling instruments